ZTS – Zoetis Inc.

Zoetis Inc.

ZTS

$151.73

Name : Zoetis Inc.

Sector : Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Mark. Cap: $67,943,477,248.00

EPSttm : 5.47

Zoetis Inc.

$151.73

4.94%

$7.88

Float Short %

1.59

Margin Of Safety %

Put/Call OI Ratio

0.48

EPS Next Q Diff

0.2

EPS Last/This Y

0.15

EPS This/Next Y

0.75

Price

151.74

Target Price

206.15

Analyst Recom

1.5

Performance Q

-6.69

Relative Volume

1.19

Beta

0.93

Ticker: ZTS

23 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-03-05	ZTS	166.96	0.43	0.67	41530
2025-03-06	ZTS	167.22	0.44	0.64	41677
2025-03-07	ZTS	170.37	0.44	4.51	41863
2025-03-10	ZTS	171.85	0.42	0.79	41373
2025-03-11	ZTS	164.38	0.42	0.71	41273
2025-03-12	ZTS	161.68	0.42	1.01	41441
2025-03-13	ZTS	160.06	0.42	2.17	41418
2025-03-14	ZTS	161.27	0.41	0.16	41233
2025-03-17	ZTS	165.21	0.41	1.52	41722
2025-03-18	ZTS	164.42	0.41	1.44	41912
2025-03-19	ZTS	163.77	0.42	1.38	42501
2025-03-20	ZTS	163.2	0.42	1.47	42753
2025-03-21	ZTS	162.96	0.42	0.47	42768
2025-03-24	ZTS	163.06	0.42	0.59	37176
2025-03-25	ZTS	161.33	0.42	0.12	37533
2025-03-26	ZTS	162.84	0.41	0.37	38225
2025-03-27	ZTS	164.97	0.41	0.37	38410
2025-03-28	ZTS	163.06	0.41	1.33	38547
2025-03-31	ZTS	164.66	0.41	0.57	38796
2025-04-01	ZTS	161.96	0.42	0.51	38907
2025-04-02	ZTS	163.5	0.42	0.77	38998
2025-04-03	ZTS	159.61	0.43	2.93	39142
2025-04-04	ZTS	151.73	0.48	8.89	40764
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

23 items 1 of 1

23 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-03-05	ZTS	166.93	1.8	108.4	6.08
2025-03-06	ZTS	167.25	1.7	171.5	6.07
2025-03-07	ZTS	170.31	1.7	227.2	6.07
2025-03-10	ZTS	171.81	1.7	194.6	6.07
2025-03-11	ZTS	164.38	1.7	23.2	6.07
2025-03-12	ZTS	161.68	1.7	112.0	6.07
2025-03-13	ZTS	160.06	1.7	133.4	6.07
2025-03-14	ZTS	161.26	1.7	191.3	6.07
2025-03-17	ZTS	165.17	1.7	246.7	6.07
2025-03-18	ZTS	164.43	1.7	151.7	6.07
2025-03-19	ZTS	163.75	1.7	152.8	6.07
2025-03-20	ZTS	163.16	1.7	154.6	6.07
2025-03-21	ZTS	163.00	1.7	163.3	6.07
2025-03-24	ZTS	163.17	1.7	169.4	6.07
2025-03-25	ZTS	161.30	1.7	128.6	6.07
2025-03-26	ZTS	162.82	1.7	197.7	6.07
2025-03-27	ZTS	164.98	1.8	210.4	6.07
2025-03-28	ZTS	163.11	1.8	128.2	6.07
2025-03-31	ZTS	164.65	1.8	197.8	6.07
2025-04-01	ZTS	161.91	1.8	111.4	6.07
2025-04-02	ZTS	163.50	1.8	199.0	6.07
2025-04-03	ZTS	159.61	1.8	87.8	6.07
2025-04-04	ZTS	151.74	1.8	3.6	6.07
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

23 items 1 of 1

23 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-03-05	ZTS	-0.93	-0.78	1.84
2025-03-06	ZTS	-0.93	-0.78	1.84
2025-03-07	ZTS	-0.93	-0.78	1.84
2025-03-10	ZTS	-0.93	-0.41	1.84
2025-03-11	ZTS	-1.26	-0.41	1.84
2025-03-12	ZTS	-1.26	-0.41	1.46
2025-03-13	ZTS	-1.26	-0.41	1.46
2025-03-14	ZTS	-1.26	-0.41	1.46
2025-03-17	ZTS	-1.26	-0.34	1.46
2025-03-18	ZTS	-1.26	-0.34	1.46
2025-03-19	ZTS	-1.26	-0.34	1.46
2025-03-20	ZTS	-1.26	-0.34	1.46
2025-03-21	ZTS	-1.26	-0.34	1.46
2025-03-24	ZTS	-1.26	-0.30	1.46
2025-03-25	ZTS	-1.26	-0.30	1.46
2025-03-26	ZTS	-1.26	-0.30	1.59
2025-03-27	ZTS	-1.26	-0.30	1.59
2025-03-28	ZTS	-1.26	-0.30	1.59
2025-03-31	ZTS	-1.26	-0.30	1.59
2025-04-01	ZTS	-1.26	-0.30	1.59
2025-04-02	ZTS	-1.26	-0.30	1.59
2025-04-03	ZTS	-1.26	-0.30	1.59
2025-04-04	ZTS	-1.26	-0.30	1.59
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

23 items 1 of 1

Last Quarter Act. EPS

1.4

Avg. EPS Est. Current Quarter

1.4

Avg. EPS Est. Next Quarter

1.6

Insider Transactions

-1.26

Institutional Transactions

-0.3

Beta

0.93

Average Sales Estimate Current Quarter

2199

Average Sales Estimate Next Quarter

2382

Fair Value

157.76

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

39.1

Max Drawdown 5-Year %

-46.5

Target Price

206.15

P/E

27.76

Forward P/E

22.4

PEG

3.43

P/S

7.34

P/B

14.27

P/Free Cash Flow

29.57

EPS

5.47

Average EPS Est. Cur. Y

6.07

EPS Next Y. (Est.)

6.83

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

26.86

Relative Volume

1.19

Return on Equity vs Sector %

32.3

Return on Equity vs Industry %

44.1

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.03

EBIT Estimation

3.6

Zoetis Inc.

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Employees: 13800

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health products in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1950 and is headquartered in Parsippany, New Jersey.

stock quote shares ZTS – Zoetis Inc. Stock Price stock today

news today ZTS – Zoetis Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch ZTS – Zoetis Inc. yahoo finance google finance

stock history ZTS – Zoetis Inc. invest stock market

stock prices ZTS premarket after hours

ticker ZTS fair value insiders trading

Investment involves risk. As a general rule, you should only trade in financial products that you are familiar with and understand the risk associated with them. The risk warning described in each financial product below is not exhaustive, you should carefully consider your investment experience, financial situation, investment objective, risk tolerance level and consult your independent financial adviser as to the suitability of your situation prior making any investment.

ZTS – Zoetis Inc.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: ZTS

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Get Started

About

Last Quarter Act. EPS

Average EPS Est. Cur. Y